Industry News 23 Oct 2026

Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca

Source: Abnewswire •By admin

This is a short summary. The full story is published by Abnewswire.

Read full story at Abnewswire
#diseases#phase ii#phase iii

Related news

Industry News
Sun Pharma to present long-term cancer drug data at ESMO 2026

UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell…

Indianpharmapost• 23 Oct 2026 •1 min read
#cancer drug#diseases#pharma
Read story
Industry News
Novo's Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…

Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…

Pr Newswire• 23 Oct 2026 •1 min read
#diseases#fda#fda approval
Read story
Industry News
Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…

Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…

Ny Newsly• 23 Oct 2026 •1 min read
#brand post#diseases#fda approval
Read story
Industry News
Novartis Pharma AG: Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with…

Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years…

Finanznachrichten.de• 23 Oct 2026 •1 min read
#control#delivered#novartis
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #vaccine #research #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit